IL-18, but not IL-12, is required for optimal cytokine production by influenza virus-specific CD8+ T cells

European Journal of Immunology

Volumn 37, Issue 2, 2007, Pages 368-375

  Denton, Alice E ^a   Doherty, Peter C ^a,b   Turner, Stephen J ^a   La Gruta, Nicole L ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

CD8+ T cells; Cytokines; Influenza A virus

Indexed keywords

CYTOKINE; EPITOPE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 18; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; EX VIVO STUDY; FEMALE; INFLUENZA; INFLUENZA VIRUS A; LUNG; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; VIROGENESIS; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; VIROLOGY;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; INFLUENZA A VIRUS; INTERLEUKIN-12; INTERLEUKIN-18; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; RECEPTORS, ANTIGEN, T-CELL;

EID: 33947717183     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200636766     Document Type: Article

References (53)

1. Okamura, H., Tsutsi, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., Torigoe, K. et al., Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995. 378: 88-91.
2. Stoll, S., Jonuleit, H., Schmitt, E., Muller, G., Yamauchi, H., Kurimoto, M., Knop, J. and Enk, A. H., Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Th1 development. Eur. J. Immunol. 1998. 28: 3231-3239.
3. Trinchieri, G., Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat, Rev. Immunol. 2003. 3: 133-146.
4. Robinson, D., Shibuya, K., Mui, A., Zonin, F., Murphy, E., Sana, T., Hartley, S. B. et al., IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB. Immunity 1997. 7: 571-581.
5. Smith, A., Santoro, F., Di Lullo, G., Dagna, L., Verani, A. and Lusso, P., Selective suppression of IL-12 production by human herpesvirus 6. Blood 2003. 102: 2877-2884.
6. Smith, A. P., Paolucci, C., Di Lullo, G., Burastero, S. E., Santoro, F. and Lusso, P., Viral replication-independent blockade of dendritic cell maturation and interleukin-12 production by human herpesvirus 6. J. Virol. 2005. 79: 2807-2813.
7. Cho, Y. S., Kang, J. W., Cho, M., Cho, C. W., Lee, S., Choe, Y. K., Kim, Y. et al., Down modulation of IL-18 expression by human papillomavirus type 16 E6 oncogene via binding to IL-18. FEBS Lett. 2001. 501: 139-145.
8. Xiang, Y. and Moss, B., IL-18 binding and inhibition of interferon gamma induction by human poxvirus-encoded proteins. Proc. Natl. Acad. Sci. USA 1999. 96: 11537-11542.
9. + T cells to innate immunity: IFN-gamma secretion induced by IL-12 and IL-18. Eur. J. Immunol. 2002. 32: 2807-2816.
10. + T cells provide an early source of IFN-gamma. J. Immunol. 2003. 170: 2399-2408.
11. + T lymphocytes, and NK cells. J. Immunol. 1992. 149: 3495-3502.
12. Chouaib, S., Chehimi, J., Bani, L., Genetet, N., Tursz, T., Gay, F., Trinchieri, G. and Mami-Chouaib, F., Interleukin 12 induces the differentiation of major histocompatibility complex class I-primed cytotoxic T-lymphocyte precursors into allospecific cytotoxic effectors. Proc. Natl. Acad. Sci. USA 1994. 91: 12659-12663.
13. Macgregor, J. N., Li, Q., Chang, A. E., Braun, T. M., Hughes, D. P. and McDonagh, K. T., Ex vivo culture with interleukin (IL)-12 improves CD8(+) T-cellacloptive immunotherapy for murine leukemia independent of IL-18 or IFN-gamma but requires perforin. Cancer Res. 2006. 66: 4913-4921.
14. + effector T cells is differentially regulated by IL-18 and IL-12. J. Immunol. 1999. 162: 3202-3211.
15. Tanaka, F., Hashimoto, W., Okamura, H., Robbins, P. D., Lotze, M. T. and Tahara, H., Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells. Cancer Res. 2000. 60: 4838-4844.
16. Micallef, M. J., Ohtsuki, T., Kohno, K., Tanabe, F., Ushio, S., Namba, M., Tanimoto, T. et al., Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: Synergism with interleukin-12 for interferon-gamma production. Eur. J. Immunol. 1996. 26: 1647-1651.
17. Chang, J., Cho, J. H., Lee, S. W., Choi, S. Y., Ha, S. J. and Sung, Y. C., IL-12 priming during in vitro antigenic stimulation changes properties of CD8 T cells and increases generation of effector and memory cells. J. Immunol. 2004. 172: 2818-2826.
18. Ehl, S., Bischoff, R., Ostler, T., Vallbracht, S., Schulte-Monting, J., Poltorak, A. and Freudenberg, M., The role of Toll-like receptor 4 versus interleukin-12 in immunity to respiratory syncytial virus. Eur. J. Immunol. 2004. 34: 1146-1153.
19. Magram, J., Connaughton, S. E., Warrier, R. R., Carvajal, D. M., Wu, C. Y., Ferrante, J., Stewart, C. et al., IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity 1996. 4: 471-481.
20. Monteiro, J. M., Harvey, C. and Trinchieri, G., Role of interleukin-12 in primary influenza virus infection. J. Virol. 1998. 72: 4825-4831.
21. + T-cell responses to influenza virus. J. Virol. 2002. 76: 10332-10337.
22. + T cell responses. J. Immunol. 2001. 166: 4627-4633.
23. Belz, G. T., Xie, W., Altman, J. D. and Doherty, P. C., A previously unrecognized H-2D (b)-restricted peptide prominent in the primary influenza A virus-specific CD8(+) T-cell response is much less apparent following secondary challenge. J. Virol. 2000. 74: 3486-3493.
24. Belz, G. T., Altman, J. D. and Doherty, P. C., Characteristics of virus-specific CD8(+) T cells in the liver during the control and resolution phases of influenza pneumonia. Proc. Natl. Acad. Sci. USA 1998. 95: 13812-13817.
25. + T cell response to influenza A viruses. J. Immunol. 2000. 165: 2404-2409.
26. + T cells in primary and secondary influenza pneumonia. Immunity 1998. 8: 683-691.
27. + T cell responses: Correlation of cytokine profile and TCR avidity. J. Immunol. 2004. 172: 5553-5560.
28. + T cells. Proc. Natl. Acad. Sci. USA 2001. 98: 6313-6318.
29. Flynn, K. J., Riberdy, J. M., Christensen, J. P., Altman, J. D. and Doherty, P. C., In vivo proliferation of naive and memory influenza-specific CD8(+) T cells. Proc. Natl. Acad. Sci. USA 1999. 96: 8597-8602.
30. Mori, L, Hossain, M. J., Takeda, K., Okamura, H., Imai, Y., Kohsaka, S. and Kimura, Y., Impaired microglial activation in the brain of IL-18-gene-disrupted mice after neurovirulent influenza A virus infection. Virology 2001. 287: 163-170.
31. Boelen, A., Kwakkel, J., Barends, M., de Bond, L., Dormans, J. and Kimman, T., Effect of lack of interleukin-4, interleukin-12, interleukin-18, or the interferon-gamma receptor on virus replication, cytokine response, and lung pathology during respiratory syncytial virus infection in mice. J. Med. Virol, 2002. 66: 552-560.
32. + T cell immuno-dominance hierarchies when antigen is limiting. J. Immunol. 2006. 177: 2917-2925.
33. + effector T cells. Proc. Nat. Acad. Sci. USA 2004. 101: 3545-3550.
34. Kersh, G. J., Kersh, E. N., Fremont, D. H. and Allen, P. M., High- and low- potency ligands with similar affinities for the TCR: The importance of kinetics in TCR signaling. Immunity 1998. 9: 817-826.
35. Matsui, K., Boniface, J. J., Steffner, P., Reay, P. A. and Davis, M. M., Kinetics of T-cell receptor binding to peptide/1-Ek complexes: Correlation of the dissociation rate with T-cell responsiveness. Proc. Natl. Acad. Sci. USA 1994. 91: 12862-12866.
36. Slifka, M. K. and Whitton, J. L., Functional avidity maturation of CDB(+) T cells without selection of higher affinity TCR. Nat. Immunol. 2001. 2: 711-717.
37. Kobayashi, M., Fitz, L., Ryan, M., Hewick, R. M., Clark, S. C., Chan, S., Loudon, R. et al., Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 1989. 170: 827-845.
38. Curtsinger, J. M., Lins, D. C. and Mescher, M. F., Signal 3 determines tolerance versus full activation of naive CD8 T cells: Dissociating proliferation and development of effector function. J. Exp. Med. 2003. 197: 1141-1151.
39. Oppmann, B., Lesley, R., Blom, B., Timans, J. C., Xu, Y., Hume, B., Vega, F. et al., Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 2000. 13: 715-725.
40. Aggarwal, S., Ghilardi, N., Xie, M. H., de Sauvage, F. J. and Gurney, A. L., Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. chem. 2003. 278: 1910-1914.
41. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005. 6: 1123-1132.
42. Liu, B., Mori, I., Hossain, M. J., Dong, L., Takeda, K. and Kimura, Y., Interleukin-18 improves the early defence system against influenza virus infection by augmenting natural killer cell-mediated cytotoxicity. J. Gen. Virol. 2004. 85: 423-428.
43. Wang, S. Z., Bao, Y. X., Rosenberger, C. L., Tesfaigzi, Y., Stark, J. M. and Harrod, K. S., IL-12p40 and IL-18 modulate inflammatory and immune responses to respiratory syncytial virus infection. J. Immunol. 2004. 173: 4040-4049.
44. Faroudi, M., Utzny, C., Salio, M., Cerumdolo, V., Guiraud, M., Muller, S. and Valitutti, S., Lyric versus stimulatory synapse in cytotoxic T lymphocyte/target cell interaction: Manifestation of a dual activation threshold. Proc. Natl. Acad. Sci. USA 2003. 100: 14145-14150.
45. Huppa, J. B., Gleimer, M., Sumen, C. and Davis, M. M., Continuous T cell receptor signaling required for synapse maintenance and full effector potential. Nat. Immunol. 2003. 4: 749-755.
46. Valitutti, S., Muller, S., Dessing, M. and Lanzavecchia, A., Different responses are elicited in cytotoxic T lymphocytes by different levels of T cell receptor occupancy. J. Exp. Med. 1996. 193: 1917-1921.
47. Wiedemann, A., Depoil, D., Faroudi, M. and Valiturti, S., Cytotoxic T lymphocytes kill multiple targets simultaneously via spatiotemporal uncoupling of lyric and stimulatory synapses. Proc. Natl. Acad. Sci. USA 2006. 103: 10985-10990.
48. Valenzuela, J., Schmidt, C. and Mescher, M., The roles of IL-12 in providing a third signal for clonal expansion of naive CD8 T cells. J. Immunol. 2002. 169: 6842-6849.
49. Gherardi, M. M., Ramirez, J. C. and Esteban, M., IL-12 and IL-18 act in synergy to clear vaccinia virus infection: Involvement of innate and adaptive components of the immune system. J. Gen. Virol. 2003. 84: 1961-1972.
50. Gracie, J. A., Robertson, S. E. and McInnes, I. B., Interleukin-18. J. Leukoc. Biol. 2003. 73: 213-224.
51. Takeda, K., Tsutsui, H., Yoshimoto, T., Adachi, O., Yoshida, N., Kishimoto, T., Okamura, H. et al., Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 1998. 8: 383-390.
52. Tannock, G. A., Paul, J. A. and Barry, R. D., Relative immunogenicity of the cold-adapted influenza virus A/Ann Arbor/6/60 (A/ AA/6/60-ca), recombinants of A/AA/6/60-ca, and parental strains with similar surface antigens. Infect. Immun. 1984. 43: 457-462.
53. Kalergis, A. M., Boucheron, N., Doucey, M. A., Palmieri, E., Goyarts, E. C., Vegh, Z., Luescher, I. F. and Nathenson, S. G., Efficient T cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex. Nat. Immunol. 2001. 2: 229-234.